Pharmaceutical outsourcing services provider PCI Pharma Services has launched its new contained packaging facility for the primary and secondary packaging of highly potent products at its Dublin site in Ireland.
Dublin
“We are very excited to officially launch our high contained packaging facility here in Ireland,” commented Bill Mitchell, president and CEO. “The recent acquisition of Millmount Healthcare and further investment in this newest specialised facility adds considerable capacity and capability to our global supply network, enabling us to meet our customers’ ever changing and evolving needs in many different geographies. Moreover, as our fourth acquisition outside the US in the past four years, this expansion further demonstrates our ability to provide our clients with a comprehensive solution to any uncertainty brought upon by ongoing negotiations between the UK and EU as a result of the evolving Brexit situation.
“The Republic of Ireland has a thriving pharmaceutical and biotech community which PCI has been fortunate to support for many years. We have already received a tremendous response to the acquisition, and investments such as this high containment packaging facility are part of our strategic plan to continue business growth and service development for our customers. PCI is proud to provide services for medicines destined to over 100 countries around the world, and the Dublin site itself to more than 50 countries.”
PCI was supported in the planning and execution of its newest facility by IDA Ireland.